Related Experiment Video
Updated: May 12, 2026

Measuring Frailty in HIV-infected Individuals. Identification of Frail Patients is the First Step to Amelioration and Reversal of Frailty
Published on: July 24, 2013
Cardiometabolic risk factors among HIV patients on antiretroviral therapy
James N Kiage1, Douglas C Heimburger, Christopher K Nyirenda
1Department of Medicine, Division of Epidemiology, Vanderbilt University, Nashville, TN 37203, USA.
Insights
Combination antiretroviral therapy (cART) in Zambia improved lipid profiles, reducing cardiovascular disease risk. However, short-term cART also showed a trend towards increased insulin resistance in HIV patients.
Area of Science:
- Cardiology
- Infectious Diseases
- Metabolic Disorders
Background:
- HIV and combination antiretroviral therapy (cART) are potential risk factors for cardiovascular disease (CVD).
- This study investigated the early impact of cART on CVD risk markers in a low-risk population in Zambia.
Purpose of the Study:
- To assess the short-term effects of initiating cART on cardiometabolic risk factors in HIV-infected adults.
- To compare these effects across different cART regimens.
Main Methods:
- Adult patients (n=118) initiating cART in Lusaka, Zambia, had cardiometabolic risk factors measured before and 90 days after treatment initiation.
- Patients were categorized into three groups based on their cART regimen.
- ANOVA was used to analyze changes in risk markers across regimens.
Main Results:
- Low high-density lipoprotein cholesterol (HDL-c) prevalence decreased significantly (78.8% to 34.8%).
- Elevated total cholesterol (TC) and insulin resistance (HOMA-IR ≥3.0) increased significantly.
- The TC:HDL-c ratio ≥5.0 prevalence decreased significantly (44.9% to 6.8%).
- These changes were independent of the specific cART regimen used.
Conclusions:
- Short-term cART in this Zambian population was associated with a cardioprotective lipid profile.
- A tendency towards increased insulin resistance was observed, irrespective of the cART regimen.
Background:
HIV and combination antiretroviral therapy (cART) may increase cardiovascular disease (CVD) risk. We assessed the early effects of cART on CVD risk markers in a population with presumed low CVD risk.
Methods:
Adult patients (n=118) in Lusaka, Zambia were recruited at the time of initiation of cART for HIV/AIDS. Cardiometabolic risk factors were measured before and 90 days after starting cART. Participants were grouped according to cART regimens: Zidovudine + Lamivudine + Nevirapine (n=58); Stavudine + Lamivudine + Nevirapine (n=43); and 'other' (Zidovudine + Lamivudine + Efavirenz, Stavudine + Lamivudine + Efavirenz, Tenofovir + Emtricitabine + Efavirenz or Tenofovir + Emtricitabine + Nevirapine, n=17). ANOVA was used to test whether changes in cardiometabolic risk markers varied by cART regimen.
Results:
From baseline to 90 days after initiation of cART, the prevalence of low levels of high-density lipoprotein cholesterol (<1.04 mmol/L for men and <1.30 mmol/L for women) significantly decreased (78.8% vs. 34.8%, P<0.001) while elevated total cholesterol (TC ≥5.18 mmol/L, 5.1% vs. 11.9%, P=0.03) and the homeostasis model assessment of insulin resistance ≥3.0 (1.7% vs. 17.0%, P<0.001) significantly increased. The prevalence of TC:HDL-c ratio ≥5.0 significantly decreased (44.9% vs. 6.8%, P<0.001). These changes in cardiometabolic risk markers were independent of the cART regimen.
Conclusion:
Our results suggest that short-term cART is associated with a cardioprotective lipid profile in Zambia and a tendency towards insulin resistance regardless of the cART regimen.
Related Concept Videos
Retrovirus Life Cycles
Coronary Artery Disease I: Introduction
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Therapeutic Drug Monitoring: Affecting Factors
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin create...
Coronary Artery Disease IV: Preventive Measures

